Business Description
Biofil Chemicals & Pharmaceuticals Ltd
ISIN : INE829A01014
Total Employee Number:
26Compare
Compare
Traded in other countries / regions
524396.India IPO Date
2000-04-19Description
Biofil Chemicals & Pharmaceuticals Ltd is an Indian pharmaceutical company. It deals in the manufacturing and trading of pharmaceuticals. Further, the company also deals in providing job work facilities with respect to the manufacturing of pharmaceutical drugs. Its product portfolio comprises basic drugs and pharmaceuticals such as sodium citrate, sodium chloride, ferrous sulphate, micro crystalline cellulose, dicyclomine hydrochloride, and others. The company's operating segments are: Pharma, which derives maximum revenue, and Chemicals. Geographically, it caters to both domestic and international markets.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.1 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 0.81 | |||||
Interest Coverage | 37.39 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.88 | |||||
Beneish M-Score | -2.51 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.9 | |||||
3-Year EBITDA Growth Rate | 43.4 | |||||
3-Year EPS without NRI Growth Rate | 71.3 | |||||
3-Year FCF Growth Rate | -87.5 | |||||
3-Year Book Growth Rate | 7.6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 25.56 | |||||
9-Day RSI | 32.02 | |||||
14-Day RSI | 37.03 | |||||
3-1 Month Momentum % | 7.82 | |||||
6-1 Month Momentum % | 21.65 | |||||
12-1 Month Momentum % | -22.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.73 | |||||
Quick Ratio | 1.54 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 50.22 | |||||
Days Sales Outstanding | 457.06 | |||||
Days Payable | 377.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -1.95 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 7.65 | |||||
Operating Margin % | 1.33 | |||||
Net Margin % | 9.81 | |||||
EBITDA Margin % | 13.14 | |||||
FCF Margin % | -2.84 | |||||
OCF Margin % | -2.13 | |||||
ROE % | 13.56 | |||||
ROA % | 5.6 | |||||
ROIC % | 1.44 | |||||
3-Year ROIIC % | -5.62 | |||||
ROC (Joel Greenblatt) % | 16.64 | |||||
ROCE % | 16.5 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 20.3 | |||||
PE Ratio without NRI | 18.76 | |||||
PEG Ratio | 4.47 | |||||
PS Ratio | 1.86 | |||||
PB Ratio | 2.42 | |||||
Price-to-Tangible-Book | 2.42 | |||||
EV-to-EBIT | 15.12 | |||||
EV-to-EBITDA | 14.02 | |||||
EV-to-Revenue | 1.85 | |||||
EV-to-FCF | -66.91 | |||||
Price-to-GF-Value | 0.78 | |||||
Price-to-Projected-FCF | 2.95 | |||||
Price-to-Median-PS-Value | 0.89 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.13 | |||||
Price-to-Graham-Number | 1.42 | |||||
| Price-to-Net-Current-Asset-Value | 3.58 | |||||
Earnings Yield (Greenblatt) % | 6.61 | |||||
FCF Yield % | -1.53 | |||||
Forward Rate of Return (Yacktman) % | 4.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biofil Chemicals & Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 283.953 | ||
| EPS (TTM) (₹) | 1.58 | ||
| Beta | 1.5588 | ||
| 3-Year Sharpe Ratio | -0.17 | ||
| 3-Year Sortino Ratio | -0.27 | ||
| Volatility % | 45.01 | ||
| 14-Day RSI | 37.03 | ||
| 14-Day ATR (₹) | 1.338651 | ||
| 20-Day SMA (₹) | 33.8855 | ||
| 12-1 Month Momentum % | -22.25 | ||
| 52-Week Range (₹) | 25.6 - 46.99 | ||
| Shares Outstanding (Mil) | 16.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biofil Chemicals & Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biofil Chemicals & Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biofil Chemicals & Pharmaceuticals Ltd Frequently Asked Questions
What is Biofil Chemicals & Pharmaceuticals Ltd(NSE:BIOFILCHEM)'s stock price today?
The current price of NSE:BIOFILCHEM is ₹32.44. The 52 week high of NSE:BIOFILCHEM is ₹46.99 and 52 week low is ₹25.60.
When is next earnings date of Biofil Chemicals & Pharmaceuticals Ltd(NSE:BIOFILCHEM)?
The next earnings date of Biofil Chemicals & Pharmaceuticals Ltd(NSE:BIOFILCHEM) is .
Does Biofil Chemicals & Pharmaceuticals Ltd(NSE:BIOFILCHEM) pay dividends? If so, how much?
Biofil Chemicals & Pharmaceuticals Ltd(NSE:BIOFILCHEM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Biofil Chemicals & Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers